Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 383  

    Article Cited by others

ORIGINAL ARTICLE

Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease

Rasulova Nigora, Lyubshin Vladimir, Arybzhanov Dauranbek, Sh. Sagdullaev, Krylov Valery, Khodjibekov Marat

Year : 2013| Volume: 12| Issue : 1 | Page no: 14-18

   This article has been cited by
 
1 Systemic Radiotherapy of Bone Metastases With Radionuclides
I. Murray,Y. Du
Clinical Oncology. 2021; 33(2): 98
[Pubmed]  [Google Scholar] [DOI]
2 Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain
Reyhaneh Manafi-Farid,Fardad Masoumi,Ghasemali Divband,Bahare Saidi,Bahar Ataeinia,Fabian Hertel,Gregor Schweighofer-Zwink,Agnieszka Morgenroth,Mohsen Beheshti
Journal of Clinical Medicine. 2020; 9(8): 2622
[Pubmed]  [Google Scholar] [DOI]
3 EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
Daria Handkiewicz-Junak,Thorsten D. Poeppel,Lisa Bodei,Cumali Aktolun,Samer Ezziddin,Francesco Giammarile,Roberto C. Delgado-Bolton,Michael Gabriel
European Journal of Nuclear Medicine and Molecular Imaging. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 NMR study of 1,7-diamino-4-oxyheptane-1,1,7,7-tetraphosphonic acid interaction with samarium(III) cation
G. S. Tsebrikova,V. E. Baulin,I. P. Kalashnikova,V. V. Ragulin,V. O. Zavelískii,G. E. Kodina,A. Yu. Tsivadze
Russian Journal of General Chemistry. 2016; 86(3): 639
[Pubmed]  [Google Scholar] [DOI]
5 Radiometabolic Treatment of Bone-Metastasizing Cancer: From186Rhenium to223Radium
Giuseppe Rubini,Adriano Nicoletti,Domenico Rubini,Artor Niccoli Asabella
Cancer Biotherapy & Radiopharmaceuticals. 2014; 29(1): 1
[Pubmed]  [Google Scholar] [DOI]

 

Read this article